Bloomberg's Krutoholow on Mylan To Sell Generic EpiPen (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010HEALTHCARE IN FOCUS: Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on Mylan selling a generic version of EpiPen to quell outcry over pricing.See omnystudio.com/listener for privacy information.